Concordia College maintains an Institutional Review Board (hereafter known as IRB) to protect the rights and welfare of humans recruited to participate in research activities conducted under the auspices of this institution. The IRB has the authority to approve, require modifications in, or disapprove ALL research involving human subjects conducted at Concordia College, as well as research conducted elsewhere by Concordia College's faculty, staff, and students.
The IRB makes its independent determination whether to approve or disapprove a protocol based upon whether or not human subjects are adequately protected. The IRB does not determine the appropriateness of the proposed research in terms of the mission, values, and traditions of Concordia College. Decisions about the appropriateness of proposed research should be made by departments or offices in consultation with the Dean of the College.
The IRB's decisions and actions are guided by the "Belmont Report", the Department of Health and Human Services (DHHS) policy, Title 45 Code of Federal Regulations (CFR), Part 46 (also known as the "Common Rule"), and by the Food and Drug Administration (FDA) policy, Title 21 CFR Part 50 and Title 21 CFR Part 56 .
The IRB delegates the responsibility for review of minimal risk research protocols conducted by students or faculty of a particular department to the chair of that department. (The chair must have completed the IRB required NIH Certification; or he or she may designate a representative who has completed the IRB required education.) No IRB member or delegate may participate in the review of any research protocol in which he/she has a conflicting interest.








